Abstract:ABSTRACT Mammalian target of rapamycin (mTOR) is a key regulator of metabolism in the mammalian cell. Here, we show the essential role for mTOR signaling in the immune response to bacterial infection. Inhibition of mTOR during infection with Staphylococcus aureus revealed that mTOR signaling is required for bactericidal free radical production by phagocytes. Mechanistically, mTOR supported glucose transporter GLUT1 expression, potentially through hypoxia-inducible factor 1α, upon phagocyte activation. Cytokine and chemokine signaling, inducible nitric oxide synthase, and p65 nuclear translocation were present at similar levels during mTOR suppression, suggesting an NF-κB-independent role for mTOR signaling in the immune response during bacterial infection. We propose that mTOR signaling primarily mediates the metabolic requirements necessary for phagocyte bactericidal free radical production. This study has important implications for the metabolic requirements of innate immune cells during bacterial infection as well as the clinical use of mTOR inhibitors. IMPORTANCE Sirolimus, everolimus, temsirolimus, and similar are a class of pharmaceutics commonly used in the clinical treatment of cancer and the anti-rejection of transplanted organs. Each of these agents suppresses the activity of the mammalian target of rapamycin (mTOR), a master regulator of metabolism in human cells. Activation of mTOR is also involved in the immune response to bacterial infection, and treatments that inhibit mTOR are associated with increased susceptibility to bacterial infections in the skin and soft tissue. Infections caused by Staphylococcus aureus are among the most common and severe. Our study shows that this susceptibility to S. aureus infection during mTOR suppression is due to an impaired function of phagocytic immune cells responsible for controlling bacterial infections. Specifically, we observed that mTOR activity is required for phagocytes to produce antimicrobial free radicals. These results have important implications for immune responses during clinical treatments and in disease states where mTOR is suppressed.

mTORC1 Signaling Regulates Proinflammatory Macrophage Function and Metabolism

Akt-Mtorc1 Signaling Regulates Acly To Integrate Metabolic Input To Control Of Macrophage Activation

Proinflammatory Signal Suppresses Proliferation and Shifts Macrophage Metabolism from Myc-dependent to HIF1α-dependent

Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide

Control of macrophage metabolism and activation by mTOR and Akt signaling

Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF–mediated myelopoiesis

mTORC1 and mTORC2 as regulators of cell metabolism in immunity

Metabolic reprogramming in macrophage responses

Metabolic Regulation of Macrophage Activation

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

The MTOR signaling pathway regulates macrophage differentiation from mouse myeloid progenitors by inhibiting autophagy

Macrophage Mtorc1 Disruption Reduces Inflammation and Insulin Resistance in Obese Mice

Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation

Coenzyme A governs proinflammatory macrophage metabolism

The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism

Metabolic reprogramming of macrophages during infections and cancer.

Elp3‐mediated codon‐dependent translation promotes mTORC2 activation and regulates macrophage polarization

The Metabolic Signature of Macrophage Responses

mTOR signaling is required for phagocyte free radical production, GLUT1 expression, and control of Staphylococcus aureus infection

The Glycolysis/hif-1Α Axis Defines the Inflammatory Role of IL-4-primed Macrophages.

MNK2 Governs the Macrophage Antiinflammatory Phenotype.